Eli Lilly has cleared a major hurdle in its bid to win European approval for its Alzheimer's disease drug Kisunla. Eli Lilly on Friday said the European Medicines Agency's Committee for Medicinal ...

Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products ...

China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...